Depression symptom trends and health domains among lung cancer patients in the CanCORS study

Lung Cancer

Volumn 100, Issue , 2016, Pages 102-109

  Sullivan, D R ^a,b   Forsberg, C W ^b   Ganzini, L ^a,b   Au, D H ^c   Gould, M K ^d,e   Provenzale, D ^f   Lyons, K S ^g   Slatore, C G ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b VETERANS AFFAIRS PORTLAND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Department of Research and Evaluation ^*  (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f DUKE UNIVERSITY   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Depression symptoms; Health domains; Lung cancer; Quality of life; Risk factors; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CONTROLLED STUDY; DEPRESSION; EUROQOL QUESTIONNAIRE; FEMALE; FOLLOW UP; GENDER; HEALTH; HIGH SCHOOL; HUMAN; LOWEST INCOME GROUP; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL COMPONENT SUMMARY; MIDDLE AGED; OBSERVATIONAL STUDY; PHYSICAL COMPONENT SUMMARY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RISK FACTOR; SHORT FORM 12; SHORT FORM 36; SMOKING; SOCIAL SUPPORT; COMPLICATION; EPIDEMIOLOGY; ETHNOLOGY; HEALTH STATUS; LUNG TUMOR; MORTALITY; PATHOLOGY; PSYCHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSION; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SURVIVAL RATE;

EID: 84989831578     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.08.008     Document Type: Article

References (86)

1. [1] Brown Johnson, C.G., Brodsky, J.L., Cataldo, J.K., Lung cancer stigma, anxiety, depression, and quality of life. J. Psychosoc. Oncol. 32 (2014), 59–73.
2. [2] Massie, M.J., Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr.(32), 2004, 57–71.
3. [3] Walker, J., Hansen, C.H., Martin, P., et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1 (2014), 343–350.
4. [4] Hopwood, P., Stephens, R.J., Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J. Clin. Oncol. 18 (2000), 893–903.
5. [5] Lo, C., Zimmermann, C., Rydall, A., et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J. Clin. Oncol. 28 (2010), 3084–3089.
6. [6] Boyes, A.W., Girgis, A., D'Este, C.A., Zucca, A.C., Lecathelinais, C., Carey, M.L., Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study. J. Clin. Oncol. 31 (2013), 2724–2729.
7. [7] Brant, J.M., Beck, S., Dudley, W.N., Cobb, P., Pepper, G., Miaskowski, C., Symptom trajectories in posttreatment cancer survivors. Cancer Nurs. 34 (2011), 67–77.
8. [8] Harrison, J.D., Young, J.M., Price, M.A., Butow, P.N., Solomon, M.J., What are the unmet supportive care needs of people with cancer: a systematic review. Support. Care Cancer 17 (2009), 1117–1128.
9. [9] Walker, J., Sawhney, A., Hansen, C.H., et al. Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol. Med. 44 (2014), 897–907.
10. [10] Li, M., Rodin, G., Psychiatric care of the medically ill. Levenson, J., (eds.) Textbook of Psychosomatic Medicine, 2011, American Psychiatric Publishing, Arlington, VA, 175–197.
11. [11] Li, M., Boquiren, V., Lo, C., Depression and anxiety in supportive oncology. Davis, M., Feyer, P., Ortner, P., (eds.) Supportive Oncology, 1st ed., 2011, Elsevier, Philadelphia, PA, 528–540.
12. [12] Sloan, J.A., Zhao, X., Novotny, P.J., et al. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J. Clin. Oncol. 30 (2012), 1498–1504.
13. [13] Ganz, P.A., Lee, J.J., Siau, J., Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67 (1991), 3131–3135.
14. [14] Ayanian, J.Z., Chrischilles, E.A., Fletcher, R.H., et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J. Clin. Oncol. 22 (2004), 2992–2996.
15. [15] Malin, J.L., Ko, C., Ayanian, J.Z., et al. Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support. Care Cancer 14 (2006), 837–848.
16. [16] Catalano, P.J., Ayanian, J.Z., Weeks, J.C., et al. Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med. Care 51 (2013), e9–e15.
17. [17] Turvey, C.L., Wallace, R.B., Herzog, R., A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int. Psychogeriatr. 11 (1999), 139–148.
18. [18] Melchior, L., Huba, G., Brown, V., Reback, C., A short depression index for women. Educ. Psychol. Meas. 53:4 (1993), 1117–11125.
19. [19] O'Halloran, A.M., Kenny, R., King-Kallimanis, B., The latent factors of depression from the short forms of the CES-D are consistent, reliable and valid in community-living older adults. Eur. Geriatr. Med. 5 (2014), 97–102.
20. [20] Bardwell, W.A., Natarajan, L., Dimsdale, J.E., et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J. Clin. Oncol. 24 (2006), 2420–2427.
21. [21] Mojtabai, R., Olfson, M., Major depression in community-dwelling middle-aged and older adults: prevalence and 2- and 4-year follow-up symptoms. Psychol. Med. 34 (2004), 623–634.
22. [22] D.E. Steffick, Documentation of Affective Functioning Measures in the Health and Retirement Study (2000) DR-005.
23. [23] Zivin, K., Pirraglia, P.A., McCammon, R.J., Langa, K.M., Vijan, S., Trends in depressive symptom burden among older adults in the United States from 1998 to 2008. J. Gen. Intern. Med. 28 (2013), 1611–1619.
24. [24] Ware, J. Jr., Kosinski, M., Keller, S.D., A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 34 (1996), 220–233.
25. [25] Johnson, J.A., Coons, S.J., Ergo, A., Szava-Kovats, G., Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13 (1998), 421–433.
26. [26] Brooks, R., Rabin, R., de Charro, F., The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. 2003, Springer, Netherlands.
27. [27] Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992), 473–483.
28. [28] Ware, J.E. Jr., Kosinski, M., Bayliss, M.S., McHorney, C.A., Rogers, W.H., Raczek, A., Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med. Care 33 (1995), AS264–79.
29. [29] Ware, J.E., Snow, K.K., Kosinski, M., Gandek, B., New England Medical Center Hospital. Health Institute. SF-36 Health Survey: Manual and Interpretation Guide. 1993, The Health Institute, New England Medical Center.
30. [30] Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85 (1993), 365–376.
31. [31] Fayers, P., Aaronson, N., Bjordal, K., Curran, D., Groenvold, M., on behalf of the EORTC Quality of Life Study Group, EORTC QLQ-C30 Scoring Manual. 3rd ed., 2001, EORTC Quality of Life Group, Brussels.
32. [32] Bergman, B., Aaronson, N.K., Ahmedzai, S., Kaasa, S., Sullivan, M., The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur. J. Cancer 30A (1994), 635–642.
33. [33] Aaronson, N., Cull, A., Kaasa, S., Sprangers, M., The EORTC modular approach to quality of life assessment in oncology. Int. J. Mental Health 23 (1994), 75–96.
34. [34] Powe, B.D., Fatalism among elderly African Americans: effects on colorectal cancer screening. Cancer Nurs. 18 (1995), 385–392.
35. [35] Powe, B., Cancer fatalism-spiritual perspectives. J. Relig. Health 36 (1997), 135–144.
36. [36] Sherbourne, C.D., Stewart, A.L., The MOS social support survey. Soc. Sci. Med. 32 (1991), 705–714.
37. [37] Sherbourne, C., Stewart, A., Wells, K., Role functioning measures. Stewart, A.L., Ware, J.E. Jr., (eds.) Measuring Functioning and Well-being: The Medical Outcomes Study Approach, 1992, Duke University Press, 205–219.
38. [38] Clough-Gorr, K.M., Ganz, P.A., Silliman, R.A., Older breast cancer survivors: factors associated with change in emotional well-being. J. Clin. Oncol. 25 (2007), 1334–1340.
39. [39] Hays, R.D., Sherbourne, C., Mazel, R., User's Manual for the Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life. 1995, RAND Corporation, Santa Monica, CA.
40. [40] Bang, D., Piccirillo, J.F., Littenberg, B., The Adult Comorbidity Evaluation-27 Test—a new comorbidity index for patients with cancer. J. Clin. Oncol., 19(Suppl), 2000 59s:abstr 1701.
41. [41] Rodin, G., Zimmermann, C., Rydall, A., et al. The desire for hastened death in patients with metastatic cancer. J. Pain Symptom Manage. 33 (2007), 661–675.
42. [42] Lee, B.O., Choi, W.J., Sung, N.Y., Lee, S.K., Lee, C.G., Kang, J.I., Incidence and risk factors for psychiatric comorbidity among people newly diagnosed with cancer based on Korean national registry data. Psychooncology 24 (2015), 1808–1814.
43. [43] Nipp, R.D., Greer, J.A., El-Jawahri, A., et al. Age and gender moderate the impact of early palliative care in metastatic non-small cell lung cancer. Oncologist 21 (2016), 119–126.
44. [44] Akechi, T., Kugaya, A., Okamura, H., Nishiwaki, Y., Yamawaki, S., Uchitomi, Y., Predictive factors for psychological distress in ambulatory lung cancer patients. Support. Care Cancer 6 (1998), 281–286.
45. [45] Baider, L., Perez, T., De-Nour, A.K., Gender and adjustment to chronic disease: a study of couples with colon cancer. Gen. Hosp. Psychiatry 11 (1989), 1–8.
46. [46] Hammerlid, E., Ahlner-Elmqvist, M., Bjordal, K., et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br. J. Cancer 80 (1999), 766–774.
47. [47] Greimel, E.R., Padilla, G.V., Grant, M.M., Gender differences in outcomes among patients with cancer. Psychooncology 7 (1998), 197–206.
48. [48] Miaskowski, C., Gender differences in pain, fatigue, and depression in patients with cancer. J. Natl. Cancer Inst. Monogr.(32), 2004, 139–143.
49. [49] Ell, K., Sanchez, K., Vourlekis, B., et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J. Clin. Oncol. 23 (2005), 3052–3060.
50. [50] Hewitt, M., Rowland, J.H., Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J. Clin. Oncol. 20 (2002), 4581–4590.
51. [51] Guidry, J.J., Aday, L.A., Zhang, D., Winn, R.J., Cost considerations as potential barriers to cancer treatment. Cancer Pract. 6 (1998), 182–187.
52. [52] Uchitomi, Y., Mikami, I., Nagai, K., Nishiwaki, Y., Akechi, T., Okamura, H., Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer. J. Clin. Oncol. 21 (2003), 69–77.
53. [53] Adler, N.E., Rehkopf, D.H., U S. disparities in health: descriptions, causes, and mechanisms. Annu. Rev. Public Health 29 (2008), 235–252.
54. [54] Ward, E., Jemal, A., Cokkinides, V., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA. Cancer J. Clin. 54 (2004), 78–93.
55. [55] Fagundes, C., Jones, D., Vichaya, E., Lu, C., Cleeland, C.S., Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference. J. Thorac. Oncol. 9 (2014), 1459–1463.
56. [56] Goldzweig, G., Andritsch, E., Hubert, A., et al. Psychological distress among male patients and male spouses: what do oncologists need to know. Ann. Oncol. 21 (2010), 877–883.
57. [57] Aizer, A.A., Chen, M.H., McCarthy, E.P., et al. Marital status and survival in patients with cancer. J. Clin. Oncol. 31 (2013), 3869–3876.
58. [58] Park, E.M., Rosenstein, D.L., Depression in adolescents and young adults with cancer. Dialogues Clin. Neurosci. 17 (2015), 171–180.
59. [59] DiMatteo, M.R., Lepper, H.S., Croghan, T.W., Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160 (2000), 2101–2107.
60. [60] Wiesbeck, G.A., Kuhl, H.C., Yaldizli, O., Wurst, F.M., WHO/ISBRA Study Group on Biological State and Trait Markers of Alcohol Use and Dependence, Tobacco smoking and depression–results from the WHO/ISBRA study. Neuropsychobiology 57 (2008), 26–31.
61. [61] Hu, M.C., Davies, M., Kandel, D.B., Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am. J. Public Health 96 (2006), 299–308.
62. [62] Breslau, N., Kilbey, M.M., Andreski, P., Nicotine dependence and major depression: new evidence from a prospective investigation. Arch. Gen. Psychiatry 50 (1993), 31–35.
63. [63] Lerman, C., Caporaso, N., Main, D., et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 17 (1998), 56–62.
64. [64] Boden, J.M., Fergusson, D.M., Horwood, L.J., Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br. J. Psychiatry 196 (2010), 440–446.
65. [65] Qi, Y., Schild, S.E., Mandrekar, S.J., et al. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J. Thorac. Oncol. 4 (2009), 1075–1082.
66. [66] Claassens, L., van Meerbeeck, J., Coens, C., et al. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J. Clin. Oncol. 29 (2011), 2104–2120.
67. [67] Sullivan, D.R., Ganzini, L., Duckart, J.P., et al. Treatment receipt and outcomes among lung cancer patients with depression. Clin. Oncol. (R. Coll. Radiol.) 26 (2014), 25–31.
68. [68] Pirl, W.F., Greer, J.A., Traeger, L., et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J. Clin. Oncol. 30 (2012), 1310–1315.
69. [69] Buccheri, G., Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur. Respir. J. 11 (1998), 173–178.
70. [70] Cocks, K., King, M.T., Velikova, G., Fayers, P.M., Brown, J.M., Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur. J. Cancer 44 (2008), 1793–1798.
71. [71] Arnold, R., Ranchor, A.V., Sanderman, R., Kempen, G.I., Ormel, J., Suurmeijer, T.P., The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual. Life Res. 13 (2004), 883–896.
72. [72] Spilker, B., Introduction in the field of quality of life trials. Spilker, B., (eds.) Quality of Life Assessment in Clinical Trials, 1990, Raven Press, New York, NY, 3–10.
73. [73] Visser, M.R., Smets, E.M., Fatigue, depression and quality of life in cancer patients: how are they related. Support. Care Cancer 6 (1998), 101–108.
74. [74] Helgeson, V.S., Cohen, S., Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol. 15 (1996), 135–148.
75. [75] Lubben, J., Gironda, M., Social support networks. Osterweil, D., Brummel-Smith, K., Beck, J., (eds.) Comprehensive Geriatric Assessment, 2000, McGraw Hill, New York, NY, 121–137.
76. [76] Kornblith, A.B., Herndon, J.E. 2nd, Zuckerman, E., et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 91 (2001), 443–454.
77. [77] Teo, A.R., Choi, H., Andrea, S.B., et al. Does mode of contact with different types of social relationships predict depression in older adults? Evidence from a nationally representative survey. J. Am. Geriatr. Soc. 63 (2015), 2014–2022.
78. [78] de Leeuw, J.R., de Graeff, A., Ros, W.J., Blijham, G.H., Hordijk, G.J., Winnubst, J.A., Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck 23 (2001), 892–898.
79. [79] Pallis, A.G., Fortpied, C., Wedding, U., et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur. J. Cancer 46 (2010), 1502–1513.
80. [80] Walker, J., Hansen, C.H., Martin, P., et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol. 15 (2014), 1168–1176.
81. [81] Powe, B.D., Cancer fatalism among African-Americans: a review of the literature. Nurs. Outlook 44 (1996), 18–21.
82. [82] Powe, B.D., Johnson, A., Fatalism as a barrier to cancer screening among African-Americans: philosophical perspectives. J. Relig. Health 34 (1995), 119–126.
83. [83] Powe, B.D., Finnie, R., Cancer fatalism: the state of the science. Cancer Nurs., 26, 2003 454,65, quiz 466–467.
84. [84] Powe, B.D., Promoting fecal occult blood testing in rural African American women. Cancer Pract. 10 (2002), 139–146.
85. [85] Karim, J., Weisz, R., Bibi, Z., ur Rehman, S., Validation of the Eight-item Center for Epidemiologic Studies Depression Scale (CES-D) among older adults. Curr. Psychol. 34 (2015), 681–692.
86. [86] D. Steffick, Documentation of Affective Functioning Measures in the Health and Retirement Study 2000, HRS/AHEAD Documentation Report.